Construction of the first laboratory at Philips Costa Rica, dedicated to the research and development of medical devices, began in September.

The laboratory will test and characterize materials and processes involved in the manufacture of image-guided therapy products. Furthermore, general research and development support will be provided to the company.
“It is great news for our plant to have a laboratory that will have a positive impact on our manufacturing processes. We are also proud to have Costa Rican human resources that will perform such a valuable and critical task for the organization,” said Mario Barquero, Plant Manager of Philips in Costa Rica.
The facility will be 130 m² in size and is expected to be completed in December.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading company in healthcare technology, focused on improving people’s health and enabling better outcomes across the entire health continuum, from healthy living and prevention, to diagnosis, treatment and home care. Philips harnesses advanced technology and deep clinical and consumer knowledge to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health information technology, as well as consumer health and home care. In 2020, Philips generated sales of €17.5 billion, and employed around 77,000 employees in sales and service areas in more than 100 countries. For news about Philips, please click on the following link: